Clinical Trials Software Market Growth Set to Surge Significantly by 2031

Clinical Trials Software Market worth $ 4.13 billion by 2030 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Software Market Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

Get Free Access to Demo Report, Excel Pivot and ToC: www.insightaceanalytic.com/request-sample/1195

According to the latest research, the global clinical trials software market is valued at US$ 1.20 Billion in 2021, and it is expected to reach US$ 4.13 Billion by 2030, with a CAGR of 15.1% during the forecast period of 2022-2030. By region, North America dominated the global market with a share of 37% in 2021.

Cell therapy aims to modify genetic material to treat different chronic diseases. Cell and gene therapy is the most significant medical advance in recent history. The increasing investments by key players in developing promising therapies and advanced packaging technologies are anticipated to fuel the market growth over the forecast period. Biopharmaceutical companies are investing in designing and manufacturing new customizable "patient-centred medicine" and modernizing their supply chains. Although biopharmaceutical firms primarily focus on drug product (DP) research and production and delivery methods (e.g., syringes), packaging and labelling are crucial to ensuring product quality and efficacy. Cell and gene therapy product packaging must maintain closure integrity and product stability and allow simple access to the product while remaining functional during heat and mechanical loads experienced. The packaging must be designed to endure cryogenic temperatures without compromising the quality of the biological material or its longevity. For instance, In February 2022, Sharp, a leading provider in contract packaging and clinical supply services, designed new purpose-built production suites to fulfil the rising demand from producers of gene treatments for dedicated and specialized packaging capacity. The innovative secondary packaging by Sharp aims to give an appropriate environment for tackling the challenges of gene treatments, notably at low temperatures and distribution in cold and ultra-cold supply chains.

Expert Knowledge, Just a Click Away:https://calendly.com/insightaceanalytic/30min?month=2024-02

In summary, packaging technology and engineering, graphics, and labelling design are vital components of the development and marketing of gene and cell therapy programs. Major driving factors of the cell therapy packaging products and services market are the increasing need for cell therapies, advancements in packaging and labelling, and the high prevalence of cancer diseases. Furthermore, advanced medical technologies, the rising trend of outsourcing in the healthcare industry, and the ongoing efforts of service providers to further improve their portfolios are enhancing the growth of the cell therapy packaging products and services market. However, the high cost of manufacturing systems, lack of standard therapy protocols, and complex procedures are restraining the growth of this market. Geographically, the North American region is the primary revenue holder of this market due to rising awareness about cell and gene therapies, increasing government investments in the research and development of cell therapies, stringent regulations, and an increasing number of chronic human diseases. On the other hand, Europe will also dominate the market during the forecast period due to advancements in the biopharmaceutical field and stringent regulations.
The Asia-Pacific market is expected to grow faster due to the growing cell therapy manufacturing industries and the adoption of new technologies.

Key market players operating in the clinical trials software market include Advarra, Antidote Technologies, Inc., ArisGlobal , AssistRx, athenahealth, Inc., Axiom Real-Time Metrics, BioClinica Inc. , BSI Business Systems Integration AG, Calyx , Castor EDC, Chronicles, Clario, Clarivate, ClinCapture, Clincase, Clinical Research, CLIRINX, Cloudbyz, Dacima Software Inc., Datatrak Int. , Florence HC , IBM , Instem , IQVIA , MasterControl Inc., Medidata Solutions Inc, MedNet Solutions Inc., Novatek International, Octalsoft , Openclinica, Oracle Corporation, Parexel International Corp., RealTime Software Solutions LLC, Reify Health, Inc., Signant Health, Statsols, TrialKit , Veeva Systems Inc., WIRB-Copernicus Group, and Other prominent players.

Key recent developments in the market:
• In December 2021, Advarra (US), the market leader in clinical site technologies and research quality and compliance consulting services, launched Advarra Cloud. The next-generation platform broadens cloud deployment options for Advarra customers and delivers applications in an easy-to-use, fully managed environment.
• In April 2021, Bioclinica (US) introduced the new source document management solution that combines advanced software with redaction and translation services to offer support to global research sites and trial management teams.
• In April 2021, Calyx, the eClinical and regulatory solutions & services provider, released Calyx CTMS v15.0, an advanced clinical trial management system on Azure cloud technology to reduce risk and improve efficiencies in clinical development.

Unlock Your GTM Strategy: www.insightaceanalytic.com/customisation/1195

Market Segments

Clinical Trials Software Market, by Type of Deployment, 2022-2030 (Value US$ Mn)
• On-cloud
• On-premises

Clinical Trials Software Market, by Type of Delivery, 2022-2030 (Value US$ Mn)
• Web-based
• Remote Monitoring

Clinical Trials Software Market, by Features of software, 2022-2030 (Value US$ Mn)
• EDC
• eCOA/ePRO
• eConsent

Clinical Trials Software Market, by End-Users, 2022-2030 (Value US$ Mn)
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Medical Device Manufacturers
• Others

Clinical Trials Software Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Clinical Trials Software Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Clinical Trials Software Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Clinical Trials Software Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Clinical Trials Software Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Clinical Trials Software Market, by Country, 2022-2030 (Value US$ Mn)
• South Africa
• GCC Countries
• Rest of Middle East & Africa

Empower Your Decision-Making with 180 Pages Full Report @ www.insightaceanalytic.com/buy-report/1195

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.